Unknown

Dataset Information

0

Binimetinib (MEK162) in recurrent low-grade serous ovarian cancer resistant to chemotherapy and hormonal treatment.


ABSTRACT: Background:Management of advanced/recurrent low-grade serous ovarian carcinoma (LGOSC) is often challenging. Effective treatment options remain limited for hormone and chemotherapy-resistant LGSOC.CASE: A 65-year-old woman with recurrent widespread LGSOC harboring the KRAS-G12?V hotspot mutation experienced a dramatic clinical response to Binimetinib (MEK162), a mitogen-activated protein kinase (MEK) inhibitor, after failing multiple chemotherapy and hormonal treatments. An 81% reduction of target lesions by RECIST 1.1 over 31?months of response duration was confirmed with serial CT scans. Episodes of drug-related toxicity (pneumonitis) easily resolved without sequelae with the use of oral steroids. Conclusion:Binimetinib may present a new treatment option for hormone- and chemotherapy-resistant LGSOC harboring KRAS mutations.

SUBMITTER: Han C 

PROVIDER: S-EPMC6014583 | biostudies-literature | 2018 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Binimetinib (MEK162) in recurrent low-grade serous ovarian cancer resistant to chemotherapy and hormonal treatment.

Han Chanhee C   Bellone Stefania S   Zammataro Luca L   Schwartz Peter E PE   Santin Alessandro D AD  

Gynecologic oncology reports 20180524


<h4>Background</h4>Management of advanced/recurrent low-grade serous ovarian carcinoma (LGOSC) is often challenging. Effective treatment options remain limited for hormone and chemotherapy-resistant LGSOC.CASE: A 65-year-old woman with recurrent widespread LGSOC harboring the KRAS-G12 V hotspot mutation experienced a dramatic clinical response to Binimetinib (MEK162), a mitogen-activated protein kinase (MEK) inhibitor, after failing multiple chemotherapy and hormonal treatments. An 81% reduction  ...[more]

Similar Datasets

| S-EPMC10570675 | biostudies-literature
| S-EPMC7655017 | biostudies-literature
| S-EPMC6195427 | biostudies-literature
| S-EPMC4095747 | biostudies-other
| S-EPMC9496900 | biostudies-literature
| S-EPMC9174542 | biostudies-literature
| S-EPMC6374783 | biostudies-literature
| S-EPMC2736318 | biostudies-literature
| S-EPMC6497146 | biostudies-literature
| S-EPMC6500912 | biostudies-literature